Related Experiment Videos
The role of TNF in cardiovascular disease
1Centro di Fisiopatologia Cardiovascolare, Fondazione 'S. Maugeri', Universita' degli Studi di Ferrara, Gussago, Brescia, Italy.
Insights
Tumour necrosis factor (TNF) significantly impacts cardiovascular disease, particularly congestive heart failure (CHF). Targeting TNF may offer new therapeutic strategies for managing CHF progression and its associated cardiac dysfunction.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Cell Biology
Background:
- Cytokines, especially tumour necrosis factor (TNF), are increasingly recognized for their role in cardiovascular diseases.
- TNF influences cardiac contractility and peripheral resistance, key determinants of cardiac function.
- Elevated TNF levels are linked to ischaemia-reperfusion injury, myocarditis, cardiac allograft rejection, and congestive heart failure (CHF) progression.
Purpose of the Study:
- To define the physiological aspects of TNF.
- To outline TNF's specific functions within the heart.
- To examine TNF's role in CHF and explore potential anti-TNF treatments.
Main Methods:
- Review of existing literature on TNF and cardiovascular disease.
- Analysis of TNF's haemodynamic and cellular effects.
- Discussion of clinical relevance and therapeutic strategies.
Main Results:
- TNF modulates cardiac contractility and peripheral resistance.
- Increased TNF is implicated in various cardiovascular pathologies, including CHF.
- In CHF, TNF may drive ventricular remodelling, down-regulate contractility, increase apoptosis, and alter nitric oxide pathways.
Conclusions:
- TNF plays a significant role in the pathophysiology of cardiovascular diseases, notably CHF.
- The involvement of TNF in CHF progression suggests potential clinical benefits from anti-TNF therapies.
- Further research into anti-TNF strategies is warranted for treating CHF.
Abstract:
There is increasing evidence that cytokines in general and tumour necrosis factor (TNF) in particular play an important role in cardiovascular disease. This is not surprising since TNF modulates both cardiac contractility and peripheral resistance, the two most important haemodynamic determinants of cardiac function. Thus, increased levels of TNF or of its soluble receptors have been implicated in the pathophysiology of ischaemia-reperfusion injury, myocarditis, cardiac allograft and, more recently, also in the progression of congestive heart failure. In this later condition, TNF could be responsible for further ventricular remodelling; down-regulation of myocardial contractility; increased rate of apoptosis of the endothelial cell and of the myocytes, alteration of the expression and function of the enzymes regulating nitric oxide production and, of course, the induction of cachexia resulting in further peripheral muscle dysfunction. The hypothesis that TNF may be involved in the progression of CHF may be of clinical relevance as anti-TNF strategies are considered for therapeutical strategies. The purposes of this article are: (1) to define the physiological aspects of TNF; (2) to outline the specific function of TNF within the heart; (3) to consider the role of TNF in CHF; and (4) to speculate on possible anti-TNF treatment.